These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 28545550)

  • 1. Genetic variation in neurodegenerative diseases and its accessibility in the model organism Caenorhabditis elegans.
    Wang YA; Kammenga JE; Harvey SC
    Hum Genomics; 2017 May; 11(1):12. PubMed ID: 28545550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurodegenerative disorders: insights from the nematode Caenorhabditis elegans.
    Dimitriadi M; Hart AC
    Neurobiol Dis; 2010 Oct; 40(1):4-11. PubMed ID: 20493260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contribution of
    Liang JJH; McKinnon IA; Rankin CH
    J Neurogenet; 2020; 34(3-4):527-548. PubMed ID: 32772603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of aging-related proteinopathies in Caenorhabditis elegans.
    Kim DK; Kim TH; Lee SJ
    Exp Mol Med; 2016 Oct; 48(10):e263. PubMed ID: 27713398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural genetic variation determines susceptibility to aggregation or toxicity in a C. elegans model for polyglutamine disease.
    Gidalevitz T; Wang N; Deravaj T; Alexander-Floyd J; Morimoto RI
    BMC Biol; 2013 Sep; 11():100. PubMed ID: 24079614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorder.
    Calahorro F; Ruiz-Rubio M
    Invert Neurosci; 2011 Dec; 11(2):73-83. PubMed ID: 22068627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodegenerative conditions associated with ageing: a molecular interplay?
    Troulinaki K; Tavernarakis N
    Mech Ageing Dev; 2005 Jan; 126(1):23-33. PubMed ID: 15610759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using C. elegans as a model for neurodegenerative diseases: Methodology and evaluation.
    Caldero-Escudero E; Romero-Sanz S; De la Fuente S
    Methods Cell Biol; 2024; 188():1-34. PubMed ID: 38880519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new role for laminins as modulators of protein toxicity in Caenorhabditis elegans.
    Jensen LT; Møller TH; Larsen SA; Jakobsen H; Olsen A
    Aging Cell; 2012 Feb; 11(1):82-92. PubMed ID: 22051349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective role of DNJ-27/ERdj5 in Caenorhabditis elegans models of human neurodegenerative diseases.
    Muñoz-Lobato F; Rodríguez-Palero MJ; Naranjo-Galindo FJ; Shephard F; Gaffney CJ; Szewczyk NJ; Hamamichi S; Caldwell KA; Caldwell GA; Link CD; Miranda-Vizuete A
    Antioxid Redox Signal; 2014 Jan; 20(2):217-35. PubMed ID: 23641861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirtuins and Autophagy in Age-Associated Neurodegenerative Diseases: Lessons from the
    Naseer A; Mir SS; Takacs-Vellai K; Nazir A
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling the functional genomics of Parkinson's disease in Caenorhabditis elegans: LRRK2 and beyond.
    Chandler RJ; Cogo S; Lewis PA; Kevei E
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34397087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presenilin mutations deregulate mitochondrial Ca
    Sarasija S; Laboy JT; Ashkavand Z; Bonner J; Tang Y; Norman KR
    Elife; 2018 Jul; 7():. PubMed ID: 29989545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy and cell death in Caenorhabditis elegans.
    Samara C; Tavernarakis N
    Curr Pharm Des; 2008; 14(2):97-115. PubMed ID: 18220822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of common genetic modifiers of neurodegenerative diseases from an integrative analysis of diverse genetic screens in model organisms.
    Chen X; Burgoyne RD
    BMC Genomics; 2012 Feb; 13():71. PubMed ID: 22333271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling neurodegenerative diseases in Caenorhabditis elegans.
    Li J; Le W
    Exp Neurol; 2013 Dec; 250():94-103. PubMed ID: 24095843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural Variation and Genetic Determinants of
    Gimond C; Vielle A; Silva-Soares N; Zdraljevic S; McGrath PT; Andersen EC; Braendle C
    Genetics; 2019 Oct; 213(2):615-632. PubMed ID: 31395653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Screen Reveals Link between the Maternal Effect Sterile Gene mes-1 and Pseudomonas aeruginosa-induced Neurodegeneration in Caenorhabditis elegans.
    Wu Q; Cao X; Yan D; Wang D; Aballay A
    J Biol Chem; 2015 Dec; 290(49):29231-9. PubMed ID: 26475858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caenorhabditis elegans mitochondrial mutants as an investigative tool to study human neurodegenerative diseases associated with mitochondrial dysfunction.
    Ventura N; Rea SL
    Biotechnol J; 2007 May; 2(5):584-95. PubMed ID: 17443764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards Understanding Neurodegenerative Diseases: Insights from
    Wu Y; Chen Y; Yu X; Zhang M; Li Z
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.